Opinion · Supreme Court of the United States

United States v. Antikamnia Chemical Co.

United States v. Antikamnia Chem. Co., 231 U.S. 654 (1914)

Type
Opinion
Court
Supreme Court of the United States
Jurisdiction
Federal
Date
1914-01-05
Topic
general

Mr. Justice McKenna delivered the opinion of the court. Libel for the seizure and condemnation of certain drugs under the provisions of the act of Congress of June 30, 1906, commonly known as the Food and Drugs Act, c. 3915, 34 Stat. 768. . The libel alleges that the drugs are in the possession and custody of The Wholesale Drug Exchange, a body corporate, at a numbered place in the City of Washington. The drugs, it is alleged, are intended to be used for the cure and mitigation and prevention of diseases of man.

Citator

UpLaw has not yet analyzed United States v. Antikamnia Chemical Co.. The absence of a flag is not a finding that it is good law.

Cited by
41 opinions

Headnotes

  1. Federal Courts & Jurisdiction — Supreme Court Jurisdiction — Authority Exercised Under the United States Where the validity of regulations made by officers to whom the power to make them has been delegated by the Food and Drugs Act of 1906 is denied, an authority exercised under the United States is drawn in question, and not merely the construction of the statute, so that the Supreme Court has jurisdiction to review the judgment of the Court of Appeals of the District of Columbia. 231 U.S. at 658
  2. Administrative Law — Delegated Power to Make Regulations The power conferred by § 3 of the Food and Drugs Act upon the specified heads of departments to make rules and regulations is an administrative power only, not a power to alter or add to the act; the extent of that power must be determined by the purpose of the act and the difficulties its execution might encounter. 231 U.S. at 665
  3. Life Sciences/Pharmaceutical — Construction — Legislative Purpose The purpose of the Food and Drugs Act of 1906 is to secure the purity of food and drugs and to inform purchasers of what they are buying; its provisions are directed to that purpose and must be construed to effect it, and the court will not attribute to a statute so important the defect of ineffectiveness as to its execution. 231 U.S. at 665
  4. Administrative Law — Delegated Power — Regulations Consistent with the Statute Regulation No. 28, requiring a label to state not only the drug contained but also the substance of which it is a derivative, is within the delegated administrative power of the Food and Drugs Act; the regulation does not enlarge or alter the act because its purpose is to fulfill the purpose of the law, rather than to leave the law effective of defeat by the easy device of mysterious names. 231 U.S. at 666
  5. Life Sciences/Pharmaceutical — Misbranding — Derivative Substances The Food and Drugs Act itself requires that a drug label disclose not only primary substances but also their derivatives, and no regulation is necessary to support that requirement; labelling tablets as containing acetphenetidin without stating that acetphenetidin is a derivative of acetanilid violates both the act and Regulation No. 28. 231 U.S. at 668
  6. Statutory Interpretation — Interpretation — Penal Character The penal character of a statute does not mean that it should not be given its reasonable intendment; where a label requirement imposes no serious burden on honest business and serves the public health as both an assurance and a warning, the statute's purpose is fairly within its language. 231 U.S. at 669